Atlas Trials

Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer

Clinical trial NCT01309607 · UNKNOWN

Trial details

NCT number
NCT01309607
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
ErbB2-Positive Stage I-III Breast Cancer
Start date
2011-04-01
Primary completion
2014-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.